Idexx Laboratories | IDXX - Ordinary Share Capital

Stock Price
648.19
Daily Change
5.20 0.81%
Monthly
-0.60%
Yearly
34.94%
Q3 Forecast
637.65

Idexx Laboratories reported $80.42M in Ordinary Share Capital for its fiscal quarter ending in June of 2025.



Financials
Stock Price USD
Assets USD 3.33B
Cash and Equivalent USD 164.59M
Cost of Sales USD 414.73M
Current Assets USD 1.36B
Current Liabilities USD 1.22B
Debt USD 1.24B
EBIT USD 373.05M
EBITDA USD 409.45M
Employees 11K
EPS Earnings Per Share USD 3.63
Equity Capital and Reserves USD -4.41B
Gross Profit on Sales USD 694.73M
Interest Expense on Debt USD 11.32M
Interest Income USD 627K
Loan Capital USD 449.81M
Market Capitalization USD 54.28B
Net Income USD 293.99M
Operating Expenses USD 736.41M
Operating Profit USD 373.05M
Ordinary Share Capital USD 80.42M
PE Price to Earnings USD 44.65
Pre-Tax Profit USD 362.35M
Sales Revenues USD 1.11B
Selling and Administration Expenses USD 259.79M
Stock USD 392.58M
Trade Creditors USD 116.59M
Trade Debtors USD 560.56M

Ordinary Share Capital Change Date
Abbott USD 25.12B 28M Mar/2025
Align Technology USD 72.48M 572K Jun/2025
Dentsply International USD 199.3M 196.3M Jun/2025
Dexcom USD 392.2M 391.8M Jun/2025
Edwards Lifesciences USD 654.8M 500K Dec/2024
Fujifilm JPY 1.2B 39.16B Jun/2025
Globus Medical USD 135.05M 134.92M Jun/2025
Henry Schein USD 121.9M 120.9M Jun/2025
Hologic USD 222.22M 219.22M Jun/2025
Idexx Laboratories USD 80.42M 63.77M Jun/2025
Insulet USD 70.39M 70.29M Jun/2025
Integra LifeSciences USD 77.92M 77M Jun/2025
Intuitive Surgical USD 358.42M 358.02M Jun/2025
Masimo USD 54.3M 54.2M Jun/2025
Neogen USD 217.04M 182.32M May/2025
ResMed USD 146.63M 145.87M Jun/2025
Roche Holding CHF 107M 0 Jun/2024
Steris USD 98.37M 4.32B Jun/2025
Tandem Diabetes Care USD 67.53M 67.46M Jun/2025
Teleflex USD 44.19M 4M Jun/2025
Thermo Fisher Scientific USD 377.49M 66.51M Jun/2025
Zoetis USD 443.95M 438.95M Jun/2025